The Brain Monitoring Market to grow USD 8.65 Billion and to record a CAGR of 6.50% by 2023-2030. According to the Industry Analysis, the market value is expected Higher Growth in the studied forecast period 2023-2030. Brain monitoring devices are used for the diagnosis and treatment of neurological diseases. It helps by analyzing the function and structure of a patient's brain. Various devices are used for monitoring such as ECG, MRI, CT scan, X-Ray, and many more.
The rising demand for these devices is also enhancing the Brain Monitoring Market Value. These devices are helpful as they monitor the electrical and neural functioning of the brain. Therefore, it is anticipated that the Asia-Pacific region will register the fastest CAGR in the forecast period. Along with that, North America and the European region are projected to hold the largest and second-largest share respectively.
One of the key factors contributing to the growth of the global market throughout the forecasted period is the rising prevalence of neurological disorders, particularly among the aging population. The rise in incidents of head injuries globally is also contributing to the growth of the global market. Elevated intracranial pressure (ICP) is a significant contributor to future cerebral injury, and the measurement of ICP has become a crucial component of cranial imaging in the aftermath of traumatic brain injury.
The projected period is anticipated to witness a surge in demand for brain monitoring devices due to the rising prevalence of neurological illnesses and developments in technology. The anticipated rise in worldwide dementia cases is projected to stimulate demand within the monitoring equipment business. Moreover, there is an increasing prevalence of many diseases and medical conditions, such as sickle cell disease and cardiac abnormalities. Cardiac procedures may sometimes impede normal cognitive function, therefore serving as a significant factor anticipated to drive the need for brain monitoring devices in the market.
June 2023:Luciole Medical successfully completed the acquisition of Spiegelberg, a prominent German medical equipment business, from SHS Capital. The financial details of this transaction have not been publicly published. The firm is involved in the activities of developing, manufacturing, and distributing products related to cerebrospinal fluid drainage, intra-abdominal pressure measurement, and intracranial pressure measurement throughout more than 60 countries. The organization engages in collaborative efforts with clinics, research institutions, and professionals in the field of neurosurgery to facilitate the development of products that align with the specific needs of patients. The two companies will integrate their product suites, manufacturing capabilities, and distribution networks in order to maximize their individual strengths and effectively provide advanced brain monitoring devices in the future. Luciole intends to use Spiegelberg's manufacturing, regulatory, and commercial skills in order to provide enhanced brain monitoring devices to a diverse patient population.
August 2023:A recently filed patent application by Apple suggests the potential incorporation of sensors in AirPods, enabling the monitoring of brain electrical activity. Apple has expedited the utilization of its gadgets as instruments for monitoring health, including both the Apple Watch series and applications for the iPhone. Currently, there is an indication that the company intends to expand its product offerings to include wireless earbuds. The business has purportedly developed a sensor system for AirPods that enables the earphones to detect and analyze electrical signals emanating from the user's brain. The patent outlines a system capable of monitoring cerebral activity. The patent discusses a system that incorporates active and reference electrodes on the exterior body of the AirPods, taking into consideration variations in ear shape and size. Additionally, the patent mentions the inclusion of additional electrodes on the ear tip.
The outbreak of COVID-19 disease had a significant impact on the market of Brain Monitoring. Lockdowns and restrictions for commuting from one place to another caused demand for remote monitoring solutions. It also increased the demand for respiratory devices such as ventilators as compared to the devices of brain monitoring. Therefore, it negatively affected the industry.
Market Drivers
The rising population of the older generation and the increasing cases of neurological diseases will drive the market of Brain Monitoring. As per the reports by World Health Organisation, in 2018, around 6.4% of over 1000 people were diagnosed with epilepsy in the US. Along with that, approximately 50 million people across the world were diagnosed with epilepsy disorder.
Restraints
The increasing costs required for monitoring and treatment of chronic neurological diseases are speculated to hinder the Brain Monitoring Market Growth.
Opportunities
The increasing opportunities such as the collaborations, partnerships, and invention of new technologies by the key players will boost the in the studied forecast period.
Challenges
It is projected the lack of required infrastructure in various countries can be a challenging factor. Also, the low- availability of skilled individuals and disruption in the supply chain will also slow down the market growth.
Value Chain Analysis
The increase in the demand for new devices for the diagnosis of neurological devices is anticipated to improve the value chain. Also, the growing population of older people will simultaneously improve the Brain Monitoring Market Trends in the studied forecast period.
The Brain Monitoring Market Size is divided into several segments such as the type, end-user, and application. Based on type, it is evaluated that MRI systems will hold a significant CAGR in the studied forecast period. However, it has high prices as compared to the X-Ray. Therefore, the X-Ray segment is evaluated to experience significant growth. It is because they are affordable as well as enhance the diagnosis.
Based on end-user, the Market segment of Brain Monitoring are Diagnostic Centres, Clinics and Hospitals, Neurological Centres, Ambulatory Surgical Centres. The research labs and clinics and hospitals segment are depicted to hold notable market share.
Based on application, the Market of Brain Monitoring is divided into Parkinson’s Disease, Stroke, Headache Disorders, Dementia, Traumatic Brain Injury (TBI), Epilepsy, Sleep Disorders, Stroke, Huntington’s Disease, and others. It is anticipated that the Stroke sub-segment will hold the largest share. Furthermore, the rising cases of stroke, headache disorders, Parkinson's disease, and epilepsy will have significant growth in the application.
Regionally, the Brain Monitoring Market Size is segmented into the Americas, Asia-Pacific, Europe, and the Rest of the World. The Americas is further divided into Latin America and North America. The Brain Monitoring Industry Analysis suggests that the Americas will hold the largest market share. The increasing cases of diseases like epilepsy and the older population are the crucial reason for the immense growth.
Secondly, Europe is anticipated to hold the second-largest share in the forecast period. The initiatives by the governments and key players in countries such as the UK, Germany, Spain, France, Italy, and the Rest of Europe are fuelling the market growth.
Apart from that, the Asia-Pacific region is anticipated to experience the fastest CAGR in the studied forecast period. For instance, in China, around 1.7 million people suffer from Parkinson's disease. Also, the increasing population of older people and the prevalence of other neurological diseases are boosting the market growth significantly.
Also, the rest of the world segment consists of Africa and the Middle East. This region is anticipated to have the least market share of Brain Monitoring. However various drivers such as investments and development will improve the market growth.
Competitive Landscape
The Brain Monitoring Market has the immense presence of various key players. These key players play important role in enhancing market growth. They do mergers, collaboration, acquisitions, etc. Some of the key players in the market are as follows.
Recent Developments
Report Overview
The overview of the Brain Monitoring Market Outlook is as follows.
Report Score and Segmentation
The report score is to provide valuable information about the Brain Monitoring Market Forecast in the studied forecast period 2021-2028. The report highlight information such as market value, drivers, segments, challenges, etc. The information collected in this report is collected from various secondary and primary sources.
Name the key players of the Brain Monitoring Market.
The key players in the Market Brain Monitoring are GE Healthcare, Nihon Kohden Corporation, Advanced Brain Monitoring, Medtronic, Integra LifeSciences, Olympus Corporation, Neurosoft, Phillips Healthcare, Dragerwerk AG& Co. KGaA, Siemens Healthineers, Masimo Corporation, NeuroWav Systems, Inc. Spiegelbrg GmbH & Co., Cadwell Industries, Nonin Medical, Inc. Natus Medical Inc., Compumedics, Natus Medical Inc. and others.
| Report Attribute/Metric | Details |
| Market Size | 8.65 Billion |
| CAGR | 6.50% |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2021 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Application, Type, End-User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Advanced Brain Monitoring,Philips Healthcare,GE Healthcare,Siemens Healthineers,Nihon Kohden Corporation,Medtronic,Drägerwerk AG & Co. KGaA,Neurosoft,Integra LifeSciences Corporation,Olympus Corporation |
| Key Market Opportunities | Increase the prevalence of epilepsy amongst the geriatric population\r\n Increasing cases of brain injuries due to road accidents \r\n Growing cases of headache disorders\r\n Increasing awareness about stroke treatment |
| Key Market Drivers | High costs associated with the treatment and monitoring |
Frequently Asked Questions (FAQ) :
Transcranial doppler is the largest segment in the brain monitoring market.
Koninklijke Philips N.V. (The Netherlands), GE Healthcare (UK), Welch Allyn (US), Spacelabs Healthcare (US), Nihon Kohden (Japan), CompuMed, Inc. (US), CardioNet (US), Schiller (Switzerland), Medtronic plc (Ireland), Natus Medical Inc. (US), CAS Medical Systems, Inc. (US), and Electrical Geodesics Incorporated (US), are some of the major players operating in the brain monitoring market.
Growing prevalence of neurological disorders, rising adoption rate of remote monitoring devices, and increasing healthcare expenditure are the major tailwinds pushing the growth of the brain monitoring market.
Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global brain monitoring market adopt to gain a larger competitive advantage.
North America holds the largest share in the brain monitoring market, followed by Europe and the Asia Pacific, respectively.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
